Synergistic Combination of Bioengineered MicroRNA and Chemotherapy Across High-Risk Neuroblastoma Subtypes
이윤영, Albatool AlKhazal, Kathleen E. Doyle, Yu-Rim Ahn, Ana Maria Sandoval-Castellanos, Mei‐Juan Tu, Ai‐Ming Yu, Jinhwan Kim, Erin G. Brown
This study evaluates bioengineered microRNA therapies combined with low-dose chemotherapy to treat high-risk neuroblastoma, showing improved efficacy and reduced toxicity.
bioRxiv · Oct 2, 2026 · PreprintBioengineering